AACR logo

More articles from Other Topics

Abstract B127: Free DNA and tolerance
Gilberto Filaci, Francesca Ferrera, Samuele Tardito, Tiziana Altosole, Cinzia Bernardi, Alessia Parodi, Daniela Fenoglio

Cancer Immunology Research Nov 2016, 4 (11 Supplement) B127; DOI: 10.1158/2326-6066.IMM2016-B127
Abstract B121: Oncogenic MYC contributes to tumor super-enhancers via eRNA amplification
Yang Eric Guo, Michael Seyffert, Brian Abraham, Xiong Ji, Richard Young

Cancer Immunology Research Nov 2016, 4 (11 Supplement) B121; DOI: 10.1158/2326-6066.IMM2016-B121
Abstract B141: Targeting the complement system to improve radiation treatment
Monica M. Olcina, Amato J. Giaccia

Cancer Immunology Research Nov 2016, 4 (11 Supplement) B141; DOI: 10.1158/2326-6066.IMM2016-B141
Abstract B130: Dysregulated Toll-like receptor responses as an oncogenic driver
Olivia Majer, Bo Liu, Angus Yiu-fai Lee, Greg Barton

Cancer Immunology Research Nov 2016, 4 (11 Supplement) B130; DOI: 10.1158/2326-6066.IMM2016-B130
Abstract B128: Clinical translation of oncolytic measles virus for T cell activation
Christine E. Engeland, Rūta Veinalde, Christof von Kalle, Dirk Jaeger, Guy Ungerechts

Cancer Immunology Research Nov 2016, 4 (11 Supplement) B128; DOI: 10.1158/2326-6066.IMM2016-B128
Abstract B144: Elucidating germinal center B cell metabolic states and their influence on selection
Harald Hartweger, Shlomo Finkin, Michel C. Nussenzweig

Cancer Immunology Research Nov 2016, 4 (11 Supplement) B144; DOI: 10.1158/2326-6066.IMM2016-B144
Abstract B132: Importance and mechanism of poly(A) tail length-mediated translational control in different immune cells
Kehui Xiang, David Bartel

Cancer Immunology Research Nov 2016, 4 (11 Supplement) B132; DOI: 10.1158/2326-6066.IMM2016-B132
Abstract B142: Long non-coding RNA expression during CD8⁺ T cell differentiation and exhaustion
William Hudson, Haydn Kissick, Masao Hashimoto, Rafi Ahmed

Cancer Immunology Research Nov 2016, 4 (11 Supplement) B142; DOI: 10.1158/2326-6066.IMM2016-B142
Abstract B126: Correlation of tumor growth inhibition by check point inhibitors with PD-L1 expression in preclinical patient derived xenograft (PDX) models
Maria Stecklum, Annika Wulf-Goldenberg, Bernadette Brzezicha, Iduna Fichtner, Jens Hoffmann

Cancer Immunology Research Nov 2016, 4 (11 Supplement) B126; DOI: 10.1158/2326-6066.IMM2016-B126
Abstract B133: Regulation of antiviral immune responses by RNase L
Jonathan Clingan, Sterling Eckard, Daphne Cooper, Hilario Ramos, Jaime Guillen, Bruno Canard, Michael Gale, Jay Hesselberth, David Barton, Daniel Stetson

Cancer Immunology Research Nov 2016, 4 (11 Supplement) B133; DOI: 10.1158/2326-6066.IMM2016-B133

Main menu

User menu

Search

More articles from Other Topics

Pages

Articles

Info for

About Cancer Immunology Research